[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100596618":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":55,"collaborators":58,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":66,"acronym":9,"eligibilityCriteria":67,"healthyVolunteers":64,"sex":68,"minAge":69,"maxAge":25,"enrollmentInfo":70,"targetDuration":25,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":25,"overallStatus":38,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Massachusetts General Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PDAC-PATHWAYS","EXPERIMENTAL","PDAC-PATHWAYS is an informational and supportive care app for patients initiating neoadjuvant therapy for PDAC.",[13],"Behavioral: PDAC-PATHWAYS",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual care","ACTIVE_COMPARATOR","Participants randomized to usual care will receive routine treatment with their oncology clinicians.",[19],"Other: Usual Care",[21,26],{"type":22,"name":9,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","A digital app for patients initiating neoadjuvant therapy for PDAC",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Usual Care","Routine treatment",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Kelsey Lau-Min, MD, MSCE","CONTACT","617-724-4000","klau-min@mgh.harvard.edu",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Boston","Massachusetts","02114","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-71.05977,42.35843,{"lat":48,"lon":47},[51,53],{"name":32,"role":33,"phone":52,"phoneExt":25,"email":35},"857-367-1486",{"name":32,"role":54,"phone":25,"phoneExt":25,"email":25},"PRINCIPAL_INVESTIGATOR",{"type":54,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Kelsey S. Lau-Min, MD","Principal Investigator",[59],{"name":60,"class":61},"United States Department of Defense","FED","100596618","pdac-pathways-a-digital-informational-and-supportive-care-app-for-patients-initiating-neoadjuvant-therapy-for-pancreatic-ductal-adenocarcinoma-100596618",false,"NCT07047807","PDAC-PATHWAYS: A Digital Informational and Supportive Care App for Patients Initiating Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma","Inclusion Criteria:\n\n* Age≥18 years\n* Within 8 weeks of a documented decision to pursue neoadjuvant therapy for newly diagnosed, non-metastatic PDAC\n* Able to comprehend and speak English\n\nExclusion Criteria:\n\n* Comorbid health condition that would interfere with study participation, as identified by the cancer care team","ALL","18 Years",{"count":71,"type":72},50,"ESTIMATED","INTERVENTIONAL",[75],"NA","This study aims to refine and pilot test PDAC-PATHWAYS, a digital informational and supportive care app for patients who are initiating neoadjuvant therapy for pancreatic ductal adenocarcinoma (PDAC).",[78],"PDAC - Pancreatic Ductal Adenocarcinoma","2026-04-15",{"date":81,"type":82},"2026-04-20","ACTUAL",{"date":84,"type":82},"2025-10-06",{"date":86,"type":72},"2027-08",{"name":5,"class":6},1]